370 related articles for article (PubMed ID: 8944829)
1. Effects of losartan on vasoconstrictor responses to angiotensin II in the forearm vascular bed of healthy volunteers.
Baan J; Chang PC; Vermeij P; Pfaffendorf M; van Zwieten PA
Cardiovasc Res; 1996 Nov; 32(5):973-9. PubMed ID: 8944829
[TBL] [Abstract][Full Text] [Related]
2. Comparison of angiotensin-converting enzyme inhibition with angiotensin II receptor antagonism in the human forearm.
Cockcroft JR; Sciberras DG; Goldberg MR; Ritter JM
J Cardiovasc Pharmacol; 1993 Oct; 22(4):579-84. PubMed ID: 7505360
[TBL] [Abstract][Full Text] [Related]
3. Forearm vasodilator response to angiotensin II in elderly women receiving candesartan: role of AT(2)- receptors.
Phoon S; Howes LG
J Renin Angiotensin Aldosterone Syst; 2002 Mar; 3(1):36-9. PubMed ID: 11984746
[TBL] [Abstract][Full Text] [Related]
4. Endogenous angiotensin II contributes to basal peripheral vascular tone in sodium deplete but not sodium replete man.
Newby DE; Masumori S; Johnston NR; Boon NA; Webb DJ
Cardiovasc Res; 1997 Nov; 36(2):268-75. PubMed ID: 9463638
[TBL] [Abstract][Full Text] [Related]
5. Effects of angiotensin II and losartan in the forearm of patients with essential hypertension.
Baan J; Chang PC; Vermeij P; Pfaffendorf M; van Zwieten PA
J Hypertens; 1998 Sep; 16(9):1299-305. PubMed ID: 9746117
[TBL] [Abstract][Full Text] [Related]
6. Regulation of angiotensin II receptor AT1 subtypes in renal afferent arterioles during chronic changes in sodium diet.
Ruan X; Wagner C; Chatziantoniou C; Kurtz A; Arendshorst WJ
J Clin Invest; 1997 Mar; 99(5):1072-81. PubMed ID: 9062366
[TBL] [Abstract][Full Text] [Related]
7. Comparative vasoconstrictor effects of angiotensin II, III, and IV in human isolated saphenous vein.
Li Q; Feenstra M; Pfaffendorf M; Eijsman L; van Zwieten PA
J Cardiovasc Pharmacol; 1997 Apr; 29(4):451-6. PubMed ID: 9156353
[TBL] [Abstract][Full Text] [Related]
8. Regulation of peripheral vascular tone in patients with heart failure: contribution of angiotensin II.
Newby DE; Goodfield NE; Flapan AD; Boon NA; Fox KA; Webb DJ
Heart; 1998 Aug; 80(2):134-40. PubMed ID: 9813557
[TBL] [Abstract][Full Text] [Related]
9. Drug concentration response relationships in normal volunteers after oral administration of losartan, an angiotensin II receptor antagonist.
Munafo A; Christen Y; Nussberger J; Shum LY; Borland RM; Lee RJ; Waeber B; Biollaz J; Brunner HR
Clin Pharmacol Ther; 1992 May; 51(5):513-21. PubMed ID: 1587065
[TBL] [Abstract][Full Text] [Related]
10. Chronic blockade of AT2-subtype receptors prevents the effect of angiotensin II on the rat vascular structure.
Levy BI; Benessiano J; Henrion D; Caputo L; Heymes C; Duriez M; Poitevin P; Samuel JL
J Clin Invest; 1996 Jul; 98(2):418-25. PubMed ID: 8755652
[TBL] [Abstract][Full Text] [Related]
11. Influence of indomethacin and L-NMMA on vascular tone and angiotensin II-induced vasoconstriction in the human forearm.
Baan J; Chang PC; Vermeij P; Pfaffendorf M; van Zwieten PA
Blood Press; 1997 Sep; 6(5):279-85. PubMed ID: 9359998
[TBL] [Abstract][Full Text] [Related]
12. Differential regulation of angiotensin II and losartan binding sites in glomeruli and mesangial cells.
Chansel D; Bizet T; Vandermeersch S; Pham P; Levy B; Ardaillou R
Am J Physiol; 1994 Mar; 266(3 Pt 2):F384-93. PubMed ID: 8160786
[TBL] [Abstract][Full Text] [Related]
13. Acute hypoxic pulmonary vasoconstriction in man is attenuated by type I angiotensin II receptor blockade.
Kiely DG; Cargill RI; Lipworth BJ
Cardiovasc Res; 1995 Dec; 30(6):875-80. PubMed ID: 8746201
[TBL] [Abstract][Full Text] [Related]
14. Effect of the AT1-receptor antagonists losartan, irbesartan, and telmisartan on angiotensin II-induced facilitation of sympathetic neurotransmission in the rat mesenteric artery.
Balt JC; Mathy MJ; Nap A; Pfaffendorf M; van Zwieten PA
J Cardiovasc Pharmacol; 2001 Jul; 38(1):141-8. PubMed ID: 11444497
[TBL] [Abstract][Full Text] [Related]
15. Human plasma protein binding of the angiotensin II receptor antagonist losartan potassium (DuP 753/MK 954) and its pharmacologically active metabolite EXP3174.
Christ DD
J Clin Pharmacol; 1995 May; 35(5):515-20. PubMed ID: 7657853
[TBL] [Abstract][Full Text] [Related]
16. Paraventricular nucleus administration of DuP753 or PD123319 inhibits the effects of angiotensin on water and sodium intake.
do-Prado MH; Camargo GM; Renzi A; Saad WA; Luiz AC; Queiróz RC; Camargo LA
Braz J Med Biol Res; 1996 Nov; 29(11):1499-502. PubMed ID: 9196552
[TBL] [Abstract][Full Text] [Related]
17. The role of angiotensin AT1 receptors in the diuretic, natriuretic, kaliuretic and blood pressure responses induced by angiotensin II activation of the median preoptic nucleus in conscious rats.
Ferreira-do-Vale C; Renzi A; Camargo GP; Saad WA; Luiz AC; Menani JV; Silveira JE; Camargo LA
Braz J Med Biol Res; 1995 Oct; 28(10):1097-101. PubMed ID: 8634683
[TBL] [Abstract][Full Text] [Related]
18. In vitro and in vivo effects of UP 269-6, a new potent orally active nonpeptide angiotensin II receptor antagonist, on vascular smooth muscle cell proliferation.
Virone-Oddos A; Desangle V; Provost D; Cazes M; Caussade F; Cloarec A
Br J Pharmacol; 1997 Feb; 120(3):488-94. PubMed ID: 9031754
[TBL] [Abstract][Full Text] [Related]
19. Losartan potassium, a nonpeptide antagonist of angiotensin II, chronically administered p.o. does not readily cross the blood-brain barrier.
Bui JD; Kimura B; Phillips MI
Eur J Pharmacol; 1992 Aug; 219(1):147-51. PubMed ID: 1397042
[TBL] [Abstract][Full Text] [Related]
20. Effects of the angiotensin type I receptor antagonist, losartan, on systemic and regional vascular responses to lower body negative pressure in healthy volunteers.
Duranteau J; Pussard E; Berdeaux A; Giudicelli JF
Br J Clin Pharmacol; 1995 Nov; 40(5):431-8. PubMed ID: 8703646
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
